| Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy TD Clemons, R Singh, A Sorolla, N Chaudhari, A Hubbard, KS Iyer Langmuir 34 (50), 15343-15349, 2018 | 162 | 2018 |
| Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ... NPJ precision oncology 4 (1), 24, 2020 | 117 | 2020 |
| An ENU mutagenesis screen identifies novel and known genes involved in epigenetic processes in the mouse L Daxinger, SK Harten, H Oey, T Epp, L Isbel, E Huang, N Whitelaw, ... Genome biology 14, 1-17, 2013 | 98 | 2013 |
| Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics A Sorolla, E Wang, E Golden, C Duffy, ST Henriques, AD Redfern, ... Oncogene 39 (6), 1167-1184, 2020 | 85 | 2020 |
| Antioxidants block proteasome inhibitor function in endometrial carcinoma cells D Llobet, N Eritja, M Encinas, A Sorolla, A Yeramian, JA Schoenenberger, ... Anti-cancer drugs 19 (2), 115-124, 2008 | 84 | 2008 |
| Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ... Oncotarget 7 (37), 60535, 2016 | 82 | 2016 |
| CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells D Llobet, N Eritja, M Encinas, N Llecha, A Yeramian, J Pallares, A Sorolla, ... Oncogene 27 (18), 2513-2524, 2008 | 78 | 2008 |
| Functional expression of voltage‐gated calcium channels in human melanoma A Das, C Pushparaj, N Bahí, A Sorolla, J Herreros, R Pamplona, R Vilella, ... Pigment cell & melanoma research 25 (2), 200-212, 2012 | 70 | 2012 |
| Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers E Wang, A Sorolla, PT Cunningham, HM Bogdawa, S Beck, E Golden, ... Oncogene 38 (1), 140-150, 2019 | 69 | 2019 |
| The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms D Llobet, N Eritja, A Yeramian, J Pallares, A Sorolla, M Domingo, ... European Journal of Cancer 46 (4), 836-850, 2010 | 61 | 2010 |
| Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway A Yeramian, A Sorolla, A Velasco, M Santacana, X Dolcet, J Valls, L Abal, ... International journal of cancer 130 (4), 967-978, 2012 | 56 | 2012 |
| Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma‐derived cell lines A Sorolla, A Yeramian, X Dolcet, AM Perez de Santos, D Llobet, ... British Journal of Dermatology 158 (3), 496-504, 2008 | 52 | 2008 |
| Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner A Yeramian, M Santacana, A Sorolla, D Llobet, M Encinas, A Velasco, ... Laboratory investigation 91 (6), 859-871, 2011 | 47 | 2011 |
| From seabed to bedside: A review on promising marine anticancer compounds E Wang, MA Sorolla, PD Gopal Krishnan, A Sorolla Biomolecules 10 (2), 248, 2020 | 45 | 2020 |
| Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells A Sorolla, A Yeramian, J Valls, X Dolcet, L Bergadà, A Llombart-Cussac, ... Molecular oncology 6 (5), 530-541, 2012 | 44 | 2012 |
| Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers JA Kretzmann, CW Evans, C Moses, A Sorolla, AL Kretzmann, E Wang, ... Chemical Science 10 (33), 7718-7727, 2019 | 42 | 2019 |
| Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides A Sorolla, E Wang, TD Clemons, CW Evans, JHC Plani-Lam, E Golden, ... Nanomedicine: Nanotechnology, Biology and Medicine 20, 102003, 2019 | 39 | 2019 |
| Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells S Shrestha, A Sorolla, J Fromont, P Blancafort, GR Flematti Marine drugs 16 (2), 53, 2018 | 36 | 2018 |
| Loss of heterozygosity in endometrial carcinoma A Velasco, J Pallares, M Santacana, A Yeramian, X Dolcet, N Eritja, ... International journal of gynecological pathology 27 (3), 305-317, 2008 | 34 | 2008 |
| Peptides, proteins and nanotechnology: A promising synergy for breast cancer targeting and treatment A Sorolla, MA Sorolla, E Wang, V Ceña Expert Opinion on Drug Delivery 17 (11), 1597-1613, 2020 | 31 | 2020 |
